Video & Transcript Research : 'hemp-derived THC'

Page 1 of 100
AL

Alabama 2025 Regular Session

Alabama Senate Healthcare Committee Mar 19th, 2025

Healthcare

Transcript Highlights:
  • I'm under the assumption that with all the derivatives that are coming out, that true hemp is mostly
  • But the Delta 9 THC in relation to the mass of the product determines whether it's hemp or not.
  • Many products with hemp-derived THC have misleading labels that fail to... have misleading labels that
  • I own a hemp farm, a hemp manufacturing facility, and two retail locations.
  • THC.
Bills: HB194, SB87, SB237
AL

Alabama 2025 Regular Session

Alabama Senate Healthcare Committee Apr 9th, 2025

Healthcare

Transcript Highlights:
  • It's the hemp bill. You and you one of the You, uh, I'm sorry. 237. We carried over at 3:36.
  • I'm working to create a resolution for a study for our state, you know, to study the implications of hemp
  • we're doing in our state and I'm we're doing in our state and I'm interested in the creation of a hemp
  • Other states have faced numerous lawsuits because of the banning of hemp products, and I don't want us
  • Let's have our hemp task force. Can I get a commitment? Is this discussing? It's a, it's a aye.
Bills: HB322, HB346, HB336, HB384, SB237
AL

Alabama 2025 Regular Session

Alabama House Health Committee Apr 8th, 2025

Health

Transcript Highlights:
  • So, um, also would any chemically altered hemp products or any synthetic marijuana be available in those
  • Second of all, this comes with a federal loophole, the farm bill in 2018, and there's certain derivatives
  • last week, there... know, as I mentioned last week, there was one product that had delta 8, delta 9, THC
  • These chemically altered hemp products.
  • These chemically altered hemp products will be available, unfortunately, still because we're not banning
Bills: HB445, HB477, SB274, HB441
MN

Minnesota 2025 1st Special Session

House Commerce Finance and Policy Committee 3/18/25

Commerce Finance and Policy

Transcript Highlights:
  • It would allow wholesalers that are currently selling these low-potency hemp-derived THC edible products
  • <00:15:47.560> derived<00:15:47.880> THC<00:15:48.839> uh these low potency
  • hemp derived THC uh these low potency hemp derived THC uh edible<00:15:49.480> products<00:15:
  • c> my the lowd do hemp THC beverage space my the lowd do hemp THC beverage space my company<00:21
  • c> actually and hemp derived Edibles uh actually and hemp derived Edibles uh actually list<00:47:
AL

Alabama 2025 Regular Session

Alabama House Health Committee Apr 2nd, 2025

Health

Transcript Highlights:
  • We have hemp-derived Delta 8... 200%.
  • If we want to continue to call this hemp, it should still be at 3% THC or less.
  • The arbitrary THC cap of 5 milligrams per serving for hemp-derived products is akin to telling someone
  • Why should we treat hemp-derived products differently when they're safer?
  • , can that come from hemp and synthetic, or is that only from naturally derived hemp?
Bills: HB441, HB445, HB477, HB441, HB445
DE

Delaware 2025-2026 Regular Session

Senate Health & Social Services Committee Meeting Jun 24th, 2026

Health & Social Services

Transcript Highlights:
  • Retailers are currently using hemp-derived or synthetically altered cannabinoids like Delta 8 to sell
  • Previously, policing these products was difficult because they were technically derived from legal hemp
  • It preserves the legal status of true industrial hemp, which is 0.3% total THC or less, ensuring Delaware's
  • What we're trying to do is show that marijuana and hemp both derive from the same plant, Cannabis sativa
  • L. ...is to show that marijuana and hemp both derive from the same plant, Cannabis sativa L., and what
Bills: HB305, HB395, HB341
Summary: The committee met in late June with Senators Hansen, Buckson, Siegfried, Townsend, and Huxable present, and first approved the meeting minutes by voice vote. The opening bill, HB 341, would limit DFS from filing child support in foster care cases unless doing so would not hinder reunification; Children’s Department staff said the department has already decided to stop filing in all such cases, with an estimated fiscal impact of about $140,000 annually. Public testimony from the League of Women Voters supported the bill as a compassionate measure to help families reunite. The committee then heard HB 446/related anaphylaxis legislation for colleges and universities, which would allow institutions to stock and use intranasal epinephrine alongside auto-injectors and update training and reporting requirements. The Asthma and Allergy Foundation of America supported the measure, emphasizing the need for needle-free options and faster treatment of anaphylaxis. The committee also took up HS1 for HB 356 on PFAS, which would ban firefighting foam containing PFAS beginning in 2028, require disclosure if PPE contains PFAS, and address recalls; DNREC and the fire service supported it, saying most departments have already transitioned away from PFAS foam. A major portion of the meeting focused on HB 305, a diabetes wellness pilot program that would use continuous glucose monitoring, app-based care coordination, lab testing, and DHIN data analysis to shift care toward prevention and remission. Sponsor Senator Siegfried described the bill as a response to Delaware’s high diabetes costs and prevalence, and the Medical Society of Delaware supported it as a proactive model. The committee also discussed HB 395, which would regulate intoxicating hemp-derived products and synthetic cannabinoids by classifying products over a THC threshold as marijuana and creating penalties for unlicensed sales; the Office of the Marijuana Commissioner supported the bill, while hemp industry representatives and Senator Hoffner warned it could harm legitimate hemp retailers and access to hemp products. The final item, HS1 for HB 332, would ban sales and marketing of kratom products to those under 21 and direct the state to study testing and regulation of kratom and synthetic variants. Supporters, including the Delaware Healthcare Association and several recovery advocates, said age-gating is a reasonable first step and that synthetic products are the main concern; opponents and some senators argued the bill should go further and fully ban kratom or better distinguish synthetic products from natural leaf kratom. No formal roll-call votes were taken on the substantive bills during the transcript, and the meeting adjourned after public comment.
OK

Oklahoma 2026 Regular Session

Alcohol, Tobacco and Controlled Substances REVISED: HB3851 - Added Feb 18th, 2026 at 10:30 am

Alcohol, Tobacco and Controlled Substances

Transcript Highlights:
  • with THC-like effects.
  • And we've had problems with kids getting hold of them and being 100 to 1,000 grams of THC in there.
  • It does not limit the amount of THC in the package.
  • I see it takes care of THC.
  • I was mainly controlled on the THC level right now.
AL

Alabama 2025 Regular Session

Alabama Senate Healthcare Committee Mar 5th, 2025

Healthcare

Transcript Highlights:
  • Again, this bill now would regulate and license or permit both hemp beverages and also hemp products
  • ... the hemp... psychoactive hemp products that are similar to the hemp beverages that were put in the
  • Uh, there isn't a per se limit for THC. It varies by... A per se limit for THC varies by user.
  • Whereas traditional marijuana is high delta 9 THC and low CBD. So because it is... THC, low CBD.
  • It depends on how many milligrams of THC... depends on how many milligrams of THC is in each gummy.
MN

Minnesota 2025-2026 Regular Session

House Commerce Finance and Policy Committee 3/25/26

Commerce Finance and Policy

Transcript Highlights:
  • Currently, the language eliminates the reference and uses the term hemp-derived consumer products, which
  • are high-dose hemp products, which are basically just cannabis products.
  • Minnesota is still the best market to launch a hemp beverage.
  • still the best market to launch a hemp still the best market to launch a hemp beverage. beverage
  • address, and license number of the hemp address, and license number of the hemp cultivator,<01:31
TX

Texas 89th 2nd C.S.

State Affairs Aug 15th, 2025

State Affairs

Transcript Highlights:
  • Hemp doesn't do that. Hemp specifically has so many uses outside of just getting people high.
  • You know, I'm not against regulations for THC. I, you know, I'm not against regulations for THC.
  • Why is alcohol okay, but THC isn't?
  • This includes THC.
  • But I need a fair amount of THC.
Bills: SB6, SB7, SB8, SB11, SB12, SB13, SB15, SB17
Summary: The committee first took up Senate Bill 8, the Texas Women's Privacy Act, and heard extensive public testimony both for and against the measure. Supporters, including representatives of Texas Values and Texas Values Action, argued the bill was needed to protect women’s privacy and safety in restrooms, locker rooms, showers, prisons, domestic violence shelters, and other government-controlled spaces, and said it would provide clear, sex-based rules. Opponents, including many transgender Texans, civil rights advocates, clergy, business and public safety voices, and others, argued the bill would invite harassment, gender policing, lawsuits, and invasive inspections, while harming trans, intersex, and gender-nonconforming people as well as cisgender women who do not fit stereotypes. Several witnesses said the bill would conflict with federal law or prison standards, worsen safety in shelters and prisons, and hurt Texas’s reputation and economy. The chair repeatedly noted the compressed special-session schedule and said flood relief remained the session’s top priority. Public testimony on SB 8 was eventually closed, and the bill was left pending. The committee then moved to Senate Bill 6, dealing with consumable hemp product restrictions. Testimony on SB 6 focused on whether the bill went too far in restricting hemp-derived THC products. Opponents argued hemp and THC have medical and economic value, that the bill would criminalize conduct and burden courts, and that regulation—not prohibition—was the better approach. Some witnesses supported tighter rules such as testing, child-resistant packaging, and limits on marketing to children, but still opposed the bill’s broad THC ban, higher fees, and age restrictions. Several speakers emphasized benefits for veterans, chronic pain patients, and small businesses, and warned that prohibition would push consumers toward the illicit market. The committee heard the testimony and then continued with additional witnesses, with no final vote or disposition reported in the excerpt.
HI
Summary: The committee heard testimony on several health-related bills. HB 1864, which would require health insurance coverage for standard fertility preservation services for people undergoing medically necessary treatment, drew broad support from SHIPA, the Department of Health, HMSA, the Hawaii Association of Health Plans, and others. Testifiers emphasized that fertility preservation is routine coverage on the mainland and important for patients facing infertility from cancer or other treatment; one patient described incurring more than $20,000 in costs. The Insurance Division flagged possible Affordable Care Act issues, a potential conflict in the bill’s language about using patient history to determine limits, and a mismatch with state medical-necessity standards. Committee discussion also focused on whether the bill should apply to all women of childbearing age rather than a narrower age-based category. HB 2305 would require nutrition and metabolic education as part of physicians’ continuing medical education. The Hawaii Medical Board opposed the measure, arguing that CME should remain flexible and tailored to each physician’s specialty and warning that topic-specific mandates can expand over time. The Office of the Governor supported the bill, saying it would help the state’s rural health transformation application and could improve federal funding prospects, though the exact impact was unclear. Members questioned whether nutrition is already covered in medical training and whether the requirement should be limited to primary care physicians; the board said Hawaii currently has no topic-specific CME mandates and that physicians can already choose relevant courses. The committee also heard strong support for HB 1597, which would establish an Alzheimer’s disease research center at the University of Hawaii. Supporters from the university, the Alzheimer’s Association, AARP, and others said the center could attract federal research dollars, expand clinical trials, and help address the state’s high Alzheimer’s-related health costs. HB 2159, which appropriates funds for health care workforce development, also received broad support from the University of Hawaii, health systems, and advocacy groups, with no opposition noted. Finally, HB 2121, which would prohibit the sale and distribution of disposable electronic smoking devices, drew support from the Department of Health, youth advocates, and public health groups citing youth addiction, environmental waste, and fire hazards; the department said a separate bill, HB 1573, would be more comprehensive and better defined for enforcement and penalties. The committee ended with HB 1913, creating a veteran services mental health coordinator position at Tripler Army Medical Center, which was supported by veteran services officials and others who said veterans need better navigation and coordination for behavioral health care.